Use este identificador para citar o ir al link de este elemento: http://hdl.handle.net/1843/78034
Tipo: Artigo de Periódico
Título: Low doses of pharmaceutical formulations loaded with UFMG-V4N2 immunogen induce the production of IgG anti-cocaine antibodies and provide evidence of cerebral protection in the preclinical model
Autor(es): Bruna Rodrigues Dias Assis
Valbert Nascimento Cardoso
Ângelo de Fátima
Frederico Duarte Garcia
Gisele Assis Castro Goulart
Maila de Castro Lourenço das Neves
Paulo Sérgio de Almeida Augusto
Raissa Lima Gonçalves Pereira
Sordaini Maria Caligiorni
Brian Sabato
Larissa Pires do Espírito Santo
Karine Dias dos Reis
Leonardo da Silva Neto
Simone Odilia Antunes Fernandes
Resumen: Anti-cocaine vaccines are a promising therapeutic strategy for treating cocaine use disorders. Here we hypothesize that nanoemulsions (NE) or suspensions (SS) loaded with the calix [4]arene-based immunogen UFMG-V4N2 can induce the production of anti-cocaine antibodies and decrease the passage of radiolabeled cocaine analog [99mTc]Trodat-1 through of the brain barrier. UFMG-V4N2 was characterized (solubility, morphology, DSC, XRD) and loaded into NEs and SSs using excipients approved for human use. Immunogenic efficacy was assessed by quantifying the titers and determining the specificity of anti-cocaine IgG antibodies, and by assessing the inhibition of [99mTc]Trodat-1 trafficking across the mice brain-barrier. UFMG-V4N2 is an amorphous, thermally stable molecule with very low hydrophilicity. The immunogenicity of NE or SS was similar, but aluminum phosphate and the lower dose of UFMG-V4N2 induced higher anti-cocaine IgG antibody titers, minimizing [99mTc]Trodat-1 uptake in the brain. Therefore, the UFMG-V4N2 may represent an alternative for the treatment of cocaine use disorder.
Asunto: Calixarenos
Química farmacêutica
Cocaína
Vacinas
Idioma: eng
País: Brasil
Editor: Universidade Federal de Minas Gerais
Sigla da Institución: UFMG
Departamento: ICX - DEPARTAMENTO DE QUÍMICA
MED - DEPARTAMENTO DE SAÚDE MENTAL
Tipo de acceso: Acesso Aberto
Identificador DOI: Https://doi.org/10.1016/j.jciso.2023.100078
URI: http://hdl.handle.net/1843/78034
Fecha del documento: 2023
metadata.dc.url.externa: https://www.sciencedirect.com/science/article/pii/S2666934X23000053?via%3Dihub
metadata.dc.relation.ispartof: JCIS Open
Aparece en las colecciones:Artigo de Periódico

archivos asociados a este elemento:
archivo Descripción TamañoFormato 
Low doses of pharmaceutical formulations loaded with UFMG-V4N2-1.pdf1.69 MBAdobe PDFVisualizar/Abrir


Los elementos en el repositorio están protegidos por copyright, con todos los derechos reservados, salvo cuando es indicado lo contrario.